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The Small GTP-Binding Protein RhoA Regulates
a Delayed Rectifier Potassium Channel
report the discovery of an additional component in a
regulatory pathway involving the Shaker family potas-
sium channel Kv1.2.
Teresa G. Cachero,² Anthony D. Morielli,²
and Ernest G. Peralta*
Department of Molecular and Cellular Biology
Tyrosine phosphorylation is a recently discoveredHarvard University
mechanism for the regulation of a number of ShakerCambridge, Massachusetts 02138
family potassium channels (Huang et al., 1993; Lev et
al., 1995; Jonas and Kaczmarek, 1996). The first example
of this phenomenon was described in a report showingSummary
that the delayed rectifier potassium channel Kv1.2 be-
comes profoundly suppressed upon its phosphorylationTyrosine kinases activated by G protein±coupled re-
by m1 muscarinic acetylcholine receptor±activated tyro-ceptors can phosphorylate and thereby suppress the
sine kinase (Huang et al.,1993). Since then, other investi-activity of the delayed rectifier potassium channel
gators have observed similar modulation in Kv1.2 (LevKv1.2. Using a yeast two-hybrid screen, we identified
et al., 1995) and the related potassium channel Kv1.5the small GTP-binding protein RhoA as a necessary
(Holmes et al., 1996).component in this process. Coimmunoprecipitation ex-
Physical association of potassium channels with regu-periments confirmed that RhoA associates with Kv1.2.
latory proteins has emerged as a major theme in potas-Electrophysiological analyses revealed that overex-
sium channel biology over thepast several years. Recentpression of RhoA markedly reduced the basal current
work has shown that the Src tyrosine kinase can physi-generated by Kv1.2 expressed in Xenopus oocytes.
cally associate with Kv1.5 to bring about its tyrosineFurthermore, in 293 cells expressing Kv1.2 and m1
kinase±dependent suppression (Holmes et al., 1996).muscarinic acetylcholine receptors, inactivating RhoA
While Kv1.2 does not associate with Src in a similar wayusing C3 exoenzyme blocked the ability of m1 recep-
(Holmes et al., 1996), the findings reported here extendtors to suppress Kv1.2 current. Therefore, these re-
the theme of protein±protein interactions underlying ty-sults demonstrate that RhoA regulates Kv1.2 activity
rosine kinase regulation of a potassium channel; weand is a central component in themechanism ofrecep-
show that the physical association of the small GTP-tor-mediated tyrosine kinase±dependent suppression
binding protein RhoA with Kv1.2 is a component in theof Kv1.2.
pathway from GPCR activation to tyrosine kinase±
dependent current suppression.
Introduction RhoA belongs to the Ras superfamily of small GTP-
binding proteins that also includes RhoB, RhoC, Rac1,
Voltage-dependent potassium channels play a central Rac2, Cdc42, RhoG, and TC10 (for reviews, see Hall,
role in processes as diverse as the modulation of synap- 1994; Nobes and Hall, 1994; Mackay et al., 1995; Ridley,
tic strength to the determination of heart rate (Hille, 1992; 1995; Takai et al., 1995; Symons, 1996; Tapon and Hall,
Yamagishi et al., 1995). Regulation of such potassium 1997). As with other small GTP-binding proteins, RhoA
channels thus serves as a cornerstone to the control cycles between two states, an inactive GDP-bound form
of a wide range of cellular events. G protein±coupled and an active GTP-bound form that translocates to the
receptor (GPCR)±activated pathways are a major source membrane where it acts upon various effector mole-
of potassium channel modulation, and therefore under- cules (Takai et al., 1995). The cycle of activation of RhoA
standing the mechanism of this regulation is a central is modulated by different proteins: guanine nucleotide
topic in cellular biology. exchange factors (GEFs) that facilitate the exchange of
Shaker family potassium channel activity is under both GDP for GTP, GTPase-activating proteins (GAPs) that
positive (Huang et al., 1994) and negative (Huang et al., stimulate the GTPase activity, and GDP-dissociation in-
1993) regulation by G protein±coupled receptors. These hibitory factors (GDIs) that inhibit the GDP-GTP ex-
channels are often localized to synaptic compartments change reaction (Boguski and McCormick, 1993). RhoA,
(Sheng et al., 1993; Veh et al., 1995), where they may but not the related small GTP-binding proteins, can be
influence the degree and kinetics of neurotransmitter selectively modified by C3 ADP-ribosyltransferase from
release or the integration of synaptic input. It has long Clostridium botulinum that ADP-ribosylates Rho at Asn41,
been known that neuronal plasticity involves the regula- a putativetarget domain of RhoA, preventing the interac-
tion of synaptic efficacy, and recently a delayed rectifier tion of RhoA with its effector proteins (Kikuchi et al.,
Shaker family potassium channel was found to partici- 1988; Sekine et al., 1989; Aktories et al., 1992; Narumiya
pate in the physiology underlying learning and memory and Morii, 1993). It has been shown that the ADP ribosy-
(Meiri et al., 1997). Therefore, the regulation of this family lation of RhoA inhibits RhoA-induced functions, such as
of potassium channels lies at the heart of a number of the formation of stress fibers (Chardin et al., 1989), focal
critical neuronal events. But despite its importance, the adhesion (Ridley and Hall, 1992), and the regulation of
mechanism by which these potassium channels can be cell motility (Takaishi et al., 1993).
regulated remains poorly understood. In this paper, we Many targets of RhoA have been described, including
phosphoinositide 5 kinase (Chong et al., 1994), phos-
phoinositide 3 kinase (Zhang et al., 1993), and phospho-*To whom correspondence should be addressed.
²These authors contributed equally to this work. lipase D (Malcolm et al., 1994) and the serine/threonine
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kinases, protein kinase N (Amano et al., 1996; Watanabe
et al., 1996), and p164 Rho-associated kinase (Leung et
al., 1995; Ishizaki et al., 1996; Matsui et al., 1996). Fur-
ther, RhoA proteins are well known to be involved in
regulating the cytoskeleton (for review, see Hall, 1994;
Takai et al., 1995; Symons, 1996), and many of those
effects occur via GPCR-activated RhoA-induced tyro-
sine kinase activity (Rankin et al., 1994; Ridley and Hall,
1994; Keller et al., 1997). Here, we report the interaction
between RhoA and the delayed rectifier potassium
channel Kv1.2. This interaction is necessary for the m1
mAChR±mediated tyrosine kinase±dependent suppres-
sion of Kv1.2. We show that RhoA physically associates
with the amino terminus of Kv1.2, and electrophysiologi-
cal analyses reveal that, in Xenopus laevis oocytes,over-
expression of RhoA markedly reduces the ionic current
generated by coexpressed Kv1.2 channels. This sup-
pression appears to require association of RhoA with
the channel, since it occurs only in channels with intact
amino termini. Further, in 293 cells expressing Kv1.2 and
m1 mAChRs, inactivating RhoA using C3 exoenzyme
blocks receptor-mediated tyrosine kinase±dependent
suppression of Kv1.2. The results presented here iden-
tify RhoA as modulator of Kv1.2 activity and as a link in
the process of GPCR-mediated tyrosine kinase sup-
pression of a potassium channel.
Figure 1. RhoA Binds to the Kv1.2 Potassium ChannelResults
(A) Top panels: the Kv1.2 and RhoA proteins are endogenously
expressed in undifferentiated NG108-15 cells. NG108-15 whole-cellThe Small GTP-Binding Protein RhoA Associates
lysates (30 mg)were analyzed by immunoblotting with anti-Kv1.2 (leftwith the Kv1.2 Potassium Channel
panel) or anti-RhoA (right panel). Bottom panel: the Kv1.2 channel
Previous research identified a tyrosine residue within coimmunoprecipitates with RhoA. Protein lysates isolated from
the amino terminus of Kv1.2 that is important for channel NG108-15 cells were immunoprecipitated with an anti-RhoA mono-
suppression by G protein±coupled receptors (Huang et clonal antibody as described in Experimental Procedures. The re-
sulting immunoprecipitates were then analyzed by immunoblottingal., 1993). We therefore sought to identify proteins that
with a polyclonal antibody specific for Kv1.2. 2 and 1 indicatecould bind to the amino terminus of the channel as
the absence or presence of anti-RhoA in the immunoprecipitates,potential modulators of Kv1.2 activity. To do so, we used
respectively. The position of Kv1.2 protein is indicated.a yeast interaction cloning approach (Fields and Song,
(B) Crude membrane fractions (500 mg) from a stable transfected
1989). Proteins encoded by a human brain fetal comple- 293-Kv1.2 cell line were immunoprecipitated with anti-RhoA follow-
mentary DNA library were screened for their ability to ing the above protocol. 2 and 1 indicate the absence or presence
of anti-RhoA antibody in the immunoprecipitates, respectively.interact with the amino-terminal 163 residue of Kv1.2.
(C) RhoA binds to the amino terminus of Kv1.2 preferentially in theWe isolated 37 cDNA clones encoding candidate inter-
GTP-bound form. In vitro translated Kv1.2 amino terminus (Kv1.2-N)actor proteins by this procedure. Interestingly, one of
(26 kDa) or Kv1.2-DN125 (42 kDa) proteins (indicated by arrows)
these clones encoded the monomeric GTP-binding pro- were incubated with purified GST-RhoA loaded with GDP or GTP.
tein RhoA (Yeramian et al., 1987). The bottom panel shows a quantitation of the experiment. Inset
Since Kv1.2 is endogenously expressed in NG108-15 shows Coomassie-stained GST and GST-RhoA proteins (5 mg each).
Similar results were obtained in two additional experiments.neuroblastoma cells (Yokoyama et al., 1989), we asked
whether we could detect interactions between RhoA
and Kv1.2 in this native system. After verifying by
1993). In its inactive state, RhoA localizes to the cyto-
Western blot analysis that RhoA and Kv1.2 are endoge-
plasm in a complex with RhoA-GDI but translocates to
nously expressed in these cells (Figure 1A, top panel),
the membrane upon activation (Takai et al., 1995). To
we carried out coimmunoprecipitation experiments. Us-
determine whether the interaction between Kv1.2 and
ing whole-cell lysates from NG108-15 cells, immunopre-
RhoA is cytoplasmic or takes place at the membrane
cipitation with anti-RhoA monoclonal antibody revealed
level, we performed coimmunoprecipitation experiments
that endogenous RhoA associates with the endogenous
in a crude membrane preparation using 293 cells stably
Kv1.2 protein (Figure 1A, bottom panel). Therefore, the
expressing Kv1.2. RhoA coimmunoprecipitates Kv1.2 in
interaction between RhoA and Kv1.2 occurs in a native the membrane (Figure 1B), suggesting that RhoA associ-
mammalian system. ates with Kv1.2 in its membrane-associated, GTP-bound
state. To investigate this possibility further, we carried
out in vitro binding experiments using in vitro translatedRhoA Binds to Kv1.2 in Its GTP-Bound Form
As with other small GTP-binding proteins, RhoA cycles Kv1.2 proteins and GST-RhoA fusion proteins (GST-
RhoA) loaded with GDP or GTP. GST-RhoA cloned intobetween two states, an inactive, GDP-bound form and
an active, GTP-bound form (Boguski and McCormick, a mammalian vector (pEBG) was transiently transfected
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Figure 2. Coexpression with RhoA Reduces
Whole-Cell Kv1.2 Currents in Xenopus Oo-
cytes
Voltage clamp currents evoked with a pulse
from 280 mV to 130 mV in 10 mV increments
from a holding potential of 260 mV. Histo-
grams depict the mean steady-state current
evoked at 130 mV and normalized to control
values. Error bars represent the standard er-
ror of the mean.
(A) Current amplitudes of representative ex-
periments of oocytes injected with RNA for
Kv1.2 alone (control) or with RNA for Kv1.2
and for either RhoA; its constitutively active
form, RhoA-QL; or the dominant-negative
form, N19RhoA (n 5 14 for each condition).
Inset depicts current traces elicited from oo-
cytes injected with Kv1.2 alone (left) or Kv1.2
and RhoA (right). The Y axes indicate the total
ionic current and are not normalized as in the
histograms. Also note different scales.
(B) Current amplitudes averaged from four
separated experiments (n . 6 each) of oo-
cytes injected with RNA for Kv1.2-DN125
alone (control) or with RhoA.
(C) Amplitudes of pharmacologically isolated
Kv1.2 current from NG108-15 cells without or
with pretreatment for 14 hr with 10 mg/ml C3
exoenzyme. Sample size indicated in paren-
theses. Additional experimental details are
given in the text.
into 293 cells. The GST-fusion proteins so produced 8 mA in controloocytes and 13 6 6 mA in those coinjected
with RhoA. The percent reduction in whole-cell currentswere purified by immobilization on glutathione-conju-
averaged for all five experiments was 62% 6 11%. Whilegated agarose beads and loaded with GTP or GDP.
coexpressing RhoA significantly reduced the steady-The complete Kv1.2 cDNA (499 amino acids) and Kv1.2
state amplitude of Kv1.2 currents, it did not affect theamino terminus (163 amino acids) were in vitro trans-
voltage dependence or kinetics of the steady-state por-lated and incubated with the GST-fusion proteins. Fol-
tion of the evoked current (Figure 2A, inset).lowing washing, proteins bound to the agarose beads
To investigate whether the reduction in Kv1.2 currentwere released by boiling and analyzed in an SDS-PAGE
is related to the guanine nucleotide binding state ofgel. The activated form of RhoA, GTP-RhoA, binds to
RhoA, we conducted similar oocyte expression studiesthe in vitro translated amino terminus of Kv1.2 (Figure
utilizing single amino acid mutant derivatives of RhoA1C) and to the entire in vitro translated Kv1.2 protein
that have beenshown previously to increaseor decrease(data not shown). In contrast, the interaction between
RhoA signaling. RhoA-QL, in which glutamine has beenGDP-RhoA and Kv1.2 was much weaker (Figure 1C).
replaced by leucine in a position analogous to that ofTherefore, RhoA binds to Kv1.2 preferentially in its acti-
codon 61of Ras, is a GTPase-deficient, activated form ofvated, GTP-bound form.
RhoA (Bourne et al., 1991). N19RhoA, in which threonineTo further define the interaction domain for RhoA
was replaced by asparagine in a position analogousbinding to Kv1.2, we constructed a deletion mutant of
to codon 17 of Ras, acts to inhibit RhoA activity byKv1.2 (Kv1.2-DN125) in which the distal 125 amino acids
competitively inhibiting the interaction of endogenous
of the amino terminus were removed. Deleting this por-
GTP-binding proteins with their respective GEFs (Feig
tion of the channel eliminates RhoA binding (Figure 1C).
and Cooper, 1988). In four of four experiments, Kv1.2
Therefore, RhoA binds primarily in its activated form to current generated in oocytes coinjected with RhoA-QL
the most distal 124 amino acids of Kv1.2. was reduced by an average of 71% 6 11% compared
to current generated in oocytes injected with Kv1.2
RhoA Modulates Kv1.2 Potassium Channel Activity alone (for each of four experiments, n 5 10, p , 0.001,
After verifying that RhoA interacts with Kv1.2, we next one tailed t test) (Figure 2A), consistent with the notion
asked whether this interaction affects Kv1.2 physiology. that RhoA in the GTP-bound state acts on Kv1.2. In
Oocytes were coinjected with cRNAs encoding Kv1.2 contrast, coexpression of a dominant-negative mutant
and various forms of the small GTP-binding protein of RhoA, N19RhoA, produced a statistically significant
RhoA. In five of six experiments, oocytes coexpressing 63% increase in Kv1.2 current over noncoinjected con-
RhoA and Kv1.2 generated outward currents that were trols (n 5 37, p , 0.001, one tailed t test) (Figure 2A),
significantly smaller than current generated in oocytes indicating that N19RhoA inhibits endogenous RhoA.
expressing Kv1.2 alone (for each experiment, n 5 14, Since overexpressing RhoA can affect the cytoskele-
p , 0.01, one tailed t test) (Figure 2A). For all five experi- ton in a variety of cells (Hall, 1994; Takai et al., 1995;
ments, the average of the mean steady-state amplitude Symons, 1996; Tapon and Hall, 1997), including Xenopus
oocytes (Mohr et al., 1990), we wished to determineof Kv1.2 current evoked by a pulse to 130 mV was 30 6
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whether the effect of RhoA on Kv1.2 arises from its
direct association with the channel or from an indirect
effect. To test whether the physiological effect of RhoA
on Kv1.2 is influenced by its association with the chan-
nel, we coexpressed RhoA and Kv1.2-DN125 inXenopus
oocytes, since this mutant channel does not bind RhoA
(Figure 1C). In four of four experiments voltage clamp
analysis of Xenopus oocytes coinjected with cRNA en-
coding Kv1.2-DN125 and RhoA generated outward cur-
rent that was not significantly different from those gener-
ated in oocytes injected with Kv1.2-DN125 alone (for
each experiment, n . 6, p , 0.3) (Figure 2B). Thus, in
an oocyte expression system, RhoA-induced reduction Figure 3. RhoA Specifically Induces Kv1.2 Current Reduction
of Kv1.2 current is correlated with the ability of RhoA Currents were evoked with a pulse from 280 mV to 130 mV in 10
to physically associate with Kv1.2. mV increments from a holding potential of 260 mV. Histograms
The previous experiments in which RhoA and Kv1.2 depict the steady-state current measured at 0 mV. Current ampli-
tudes of representative experiments of oocytes injected with RNAwere coexpressed in an ectopic system predict that
for Kv1.2 and either RhoA, Rac1, Cdc42, or Rab4 (n 5 8 for eachthese two proteins may interact in a similar way within
condition) are shown. Similar results were obtained in three addi-a native system. To test this possibility, we again used
tional experiments.NG108-15 neuroglioma cells since they express high
endogenous levels of both RhoA and Kv1.2 (Figure 1A,
top panel). Since Kv1.2 is relatively insensitive to the
with RNA encoding for either Rac1 (3.2 6 0.2 mA, n 5potassium channel blocker tetraethylamonium (TEA)
8), Cdc42Hs (3.5 6 0.6 mA, n 5 8), or Rab4 (2.9 6 0.4(Paulmichi et al., 1991), Kv1.2 current can be pharmaco-
mA, n 5 8). Therefore, the inhibition of Kv1.2 current islogically isolated from the other major potassium cur-
specific to RhoA.rents present in these cells (Yokoyama et al., 1989). In
NG108-15 cells, Kv1.2 current isolated using TEA retains
RhoA Is Involved in the Receptor-Mediatedthe properties of Kv1.2 current expressed in Xenopus
Suppression of Kv1.2 Currentoocytes or human 293 cells and has been shown to
We had previously shown that mutating the amino-ter-undergo tyrosine kinase±dependent suppression upon
minal tyrosine 132 to phenylalanine (Kv1.2-Y132F chan-activation of the endogenously expressed bradykinin
nels) conferred resistance to tyrosine kinase±dependentreceptor (Huang et al., 1993). Because of the high levels
suppression by m1 mAChRs (86% suppressionfor Kv1.2of RhoA expressed in NG108-15 cells, we reasoned that
vs. 44% suppression for Kv1.2-Y132F) (Huang et al.,a portion of the endogenous Kv1.2 current may exhibit
1993). If RhoA-mediated reduction of Kv1.2 currentconstitutive RhoA-induced reduction. To test this possi-
occurs by a mechanism similar to mAChR-mediatedbility, we inactivated endogenous RhoA in NG108-15
suppression, Kv1.2-Y132F channels should also exhibitcells with the specific inhibitor Clostridium botulinum
resistance to RhoA-mediated reduction. To test this hy-C3 ADP-ribosyltransferase (Sekine et al., 1989; Sugai et
pothesis, we again used Xenopus oocytes as an expres-al., 1992) and measured the effect of that inhibition on
sion system by coinjecting oocytes with RNA for Kv1.2the amplitude of the TEA-insensitive Kv1.2 potassium
or Kv1.2-Y132F and the constitutively active form ofcurrent. The steady-state outward current generated by
RhoA, RhoA-QL. Coexpression of RhoA-QL caused aa voltage step to 130 mV incontrol cells averaged 347 6
significant reduction in the current from both Kv1.2 (p ,36 pA, n 5 10. In contrast, cells pretreated with 10 mg/
0.001, one tailed t test) and Kv1.2-Y132F (p , 0.02, oneml C3 exoenzyme for 14 hr exhibited a significantly (p ,
tailed t test) channels. However, the degree of RhoA-QL0.01, one tailed t test) greater mean outward current of
reduction of Kv1.2-generated current was significantly615 6 96 pA, n 5 8 (Figure 2C). Thus, RhoA causes a
greater than that observed for Kv1.2-Y132F±generatedreduction in Kv1.2-generated current in both ectopic
current (79%, n 5 21 vs. 35%, n 5 22 respectively; p ,and native systems.
0.01, one tailed t test) (Figure 4). Therefore, mutating
tyrosine 132 to phenylalanine confers resistance not
only to suppression by mAChRs but to coexpressedReduction of Kv1.2 Activity Is Specific to RhoA
We next asked whether the reduction of Kv1.2 current RhoA-QL as well. These data suggest that RhoA lies in
the pathway linking m1 mAChR activation to tyrosineby RhoA is specific or is a general feature of Rho family
GTPases. We addressed this question by testing the kinase±dependent channel suppression.
Tyrosine kinase±dependent suppression of Kv1.2 oc-effects of the Rho family members Rac1 and Cdc42 on
Kv1.2 current. As a negative control, we also tested the curs in a variety of mammalian cell lines, including hu-
man embryonic 293 kidney cells (Huang et al., 1993; Leveffect of the more distantly related small GTP-binding
protein, Rab4 (Nuoffer and Balch, 1994). Figure 3 sum- et al., 1995). Since overexpression of RhoA is coincident
with a reduction in Kv1.2 current, we wished to testmarizes the results obtained in these experiments. The
mean of currents evoked in oocytes coinjected with whether endogenously expressed RhoA could influence
m1 mAChR-mediated suppression of Kv1.2. To do so weKv1.2 and RhoA (1.2 6 0.2 mA, n 5 8) was significantly
smaller (for each condition, p , 0.002, one tailed t test) used C3 exoenzyme to inactivate endogenous RhoA in
293 cells stably expressing both Kv1.2 and m1 mAChRs.than those of currents generated in oocytes coinjected
RhoA Modulates Kv1.2 Activity
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pretreating the cells with 10 mg/ml C3 exoenzyme for
14 hr abolished the ability of carbachol to suppress
Kv1.2 current (mean current amplitude generated by a
pulse to 0 mV was 1.3 6 0.3 nA without carbachol, n 5
5, and 1.7 6 0.3 nA in 1 mM carbachol, n 5 5) (Figure
5B). This result did not arise from a general uncoupling
of the m1 mAChR from its normal signal transduction
pathway, since calcium imaging revealed no effect of
C3 exoenzyme on carbachol-stimulated intracellular cal-
cium release (Figure 5B, inset). Indeed, far from uncou-
pling the m1 receptor, C3 exoenzyme appears to have
unmasked a carbachol-induced facilitation of Kv1.2 cur-
rent (Figure 5B).
Figure 4. Mutating the Amino-Terminal Tyrosine 132 of Kv1.2 to To experimentally maximize the magnitude of Kv1.2
Phenylalanine Inhibits Channel Suppression by RhoA-QL current suppression evoked by m1 mAChRs, it is neces-
Voltage clamp currents were evoked with a pulse from 260 mV to sary to pretreat 293 cells with the tyrosine phosphatase
110 mV. Graphs represent mean steady-state current normalized inhibitor orthovanadate (1 mM for .10 min, Figures 5A
to the mean values from channels not coinjected with RhoA-QL. and 5C). Orthovanadate treatment appears to not dis-
Data are from two experiments using separate batches of oocytes
rupt m1 mAChR-mediated signaling, since it has no ef-after normalization. Error bars represent the standard error of the
fect on the calcium transient evoked by application ofmean. Sample size is indicated in parentheses.
1 mM carbachol (Figure 5C, inset). In the presence of 1
mM orthovanadate, carbachol-reduced Kv1.2 gener-
ated current by 85% in control cells (mean currentampli-In control cells, exposure to 1 mM carbachol for at least
tude from a pulse to 0 mV was 1.25 6 0.30 nA without10 min produced a 40% reduction in the amount of
carbachol, n 5 5, and 0.19 6 0.07 nA in 1 mM carbachol,current generated by Kv1.2 channels in response to a
n 5 5) (Figure 5C) and by 58% in cells pretreated withfamily of voltage steps from 270 mV to 150 mV (mean
C3 exoenzyme (mean current amplitude from a pulse tocurrent amplitude generated by a pulse to 0 mV was
0 mV was 1.09 6 0.21 nA without carbachol, n 5 4, and1.3 6 0.1 nA without carbachol, n 5 5, and 0.8 6 0.1
nA in 1 mM carbachol, n 5 5) (Figure 5A). In contrast, 0.46 6 0.10 nA in 1 mM carbachol, n 5 6) (Figure 5D).
Figure 5. Inactivating RhoA with C3 Exoenzyme Disrupts m1 mAChR±Mediated Suppression of Kv1.2
(A) Average whole-cell currents evoked in 293 cells with pulses from 270 to 150 mV in increments of 10 mV before (left, n 5 5) or after (right,
n 5 5) treatment with 1 mM carbachol.
(B) Average whole-cell currents recorded before (left, n 5 5) and after (right, n 5 5) treatment with 1 mM carbachol from 293 cells pretreated
with 10 mg/ml of C3 exoenzyme for 14 hr. The inset shows calcium transients evoked by 1 mM carbachol applied at the 2 min time point in
293 cells pretreated (light trace) or not treated (heavy trace) with 10 mg/ml of C3 exoenzyme for 14 hr.
(C and D) Identical protocols were followed as in (A) and (B) except that the cells were pretreated for 10 min with 1 mM orthovanadate. The
inset shows calcium transients evoked by 1 mM carbachol applied at the 2 min time point in 293 cells pretreated (light trace) or not treated
(heavy trace) with 1 mM orthovanadate.
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Therefore, the extent of carbachol-induced Kv1.2 cur- RhoA. To test whether the physical association of RhoA
with Kv1.2 is required for the RhoA-induced effect onrent suppression was significantly reduced (p , 0.03,
one tailed t test) in cells treated with C3 exoenzyme Kv1.2 ionic current, we used a mutant channel deficient
in RhoA binding. Our finding that amino-terminal trun-even in the presence of orthovanadate. These results
suggest that RhoA participates in the m1 mAChR±medi- cated Kv1.2 channels fail to become significantly sup-
pressed by overexpression of RhoA indicates that theated, tyrosine kinase±dependent suppression of this
channel. physical association of RhoA with Kv1.2 is necessary
for its effect on Kv1.2 physiology. Therefore, RhoA may
induce channel suppressionas a direct result of its phys-
Discussion ical association with Kv1.2 or by localizing downstream
components of the suppression pathway, for example a
We have sought to identify components in the pathway tyrosine kinase, to the channel. We showed that mutant
of m1 muscarinic acetylcholine receptor (mAChR)±medi- Kv1.2-Y132F channels, which are resistant to receptor-
ated tyrosine kinase±dependent suppression of Kv1.2 mediated suppression by tyrosine kinase activity, are
potassium channels. Since tyrosine residue 132 located also resistant to suppression by RhoA. RhoA induced
on the cytoplasmic amino terminus is required for maxi- a small but significant suppression of Kv1.2-Y132F cur-
mal suppression of Kv1.2 current (Huang et al., 1993), rent and, interestingly, the degree of suppression by
we reasoned that this region of the channel might be a RhoA is identical to that produced by m1 mAChRs (Hu-
site of interaction with other proteins involved in channel ang et al., 1993). Because the effects of m1 mAChRs
modulation. In this report, we identify the small GTP- and RhoA on Kv1.2-Y132F channels are nearly identical,
binding protein RhoA as such a protein. Our data con- it seems likely that both act as part of a common mecha-
tributes to a growing body of data indicating that small nism. However, a definitive answer to this question
GTP-binding proteins may be involved in ion channel awaits further analysis.
regulation (Yatani et al., 1991; Fitzgerald and Dolphin, RhoA has a central role in regulating the actin cy-
1995; Zhong, 1995; Wilk-Blaszczak et al., 1997). toskeleton (Hall, 1994; Takai et al., 1995; Symons, 1996;
Our finding that RhoA associateswith the amino termi- Tapon and Hall, 1997), suggesting the intriguing possi-
nus of Kv1.2 in a two hybrid assay was confirmed in a bility of a role for the cytoarchitecture in regulating either
series of immunoprecipitation experiments. In human em- the steady-state activity of Kv1.2 or its ability to become
bryonic kidney 293 cellsoverexpressing Kv1.2, immuno- suppressed by GPCR signaling. However, since Kv1.2-
precipitation using an anti-RhoA antibody revealed an Y132F channels are resistant to RhoA-induced current
association of RhoA with Kv1.2. This interaction was reduction, any RhoA effects on the cytoarchitecture
robust, since it was maintained even under the stringent would most likely act in concert with tyrosine kinase
conditions of our immunoprecipitation assay. The inter- activity on Kv1.2. Since RhoA can increase tyrosine ki-
action did not result from overexpression of Kv1.2 but nase activity in a number of systems in a manner inde-
instead exists under native conditions since it also oc- pendent of its effect on the actin cytoskeleton (Barry
curs in a neuronal cell line, NG108-15, expressing en- and Critchley, 1994; Rankin et al., 1994; Keller et al.,
dogenous Kv1.2 and RhoA. 1997), one interpretation of our results is that Kv1.2
The inactive form of RhoA, GDP-RhoA, is complexed suppression involves a pathway from GPCR to RhoA to
with Rho-GDI, and this complex localizes to the cyto- tyrosine kinase to Kv1.2, with RhoA serving to localize
plasmic compartment of the cell. Upon activation, RhoA a tyrosine kinase activity to the channel rather than di-
dissociates from Rho-GDI, allowing the exchange of rectly suppressing channel activity itself. However, it is
GDP for GTP.Once in its GTP-bound form,RhoA translo- equally possible that RhoA may evoke Kv1.2 current
cates to the membrane fraction where it acts upon vari- suppression by a mechanism dependent upon but not
ous effector molecules (Takai et al., 1995). Our finding causal to tyrosine phosphorylation of Kv1.2. For exam-
that RhoA can immunoprecipitate Kv1.2 in purified ple, RhoA binding may indeed constitute the ultimate
membranes indicates that Kv1.2 associates with the effector for Kv1.2 current suppression and that binding
active, GTP-bound form of RhoA (Figure 1B). To confirm may depend upon the tyrosine phosphorylation state of
this finding, we performed in vitro binding experiments, the channel.
which demonstrated that the GTP-bound form of RhoA Having established that the direct association of acti-
associates with the amino terminus of Kv1.2 preferen- vated RhoA leads to the suppression of Kv1.2 current,
tially over the GDP-bound form (Figure 1C). Therefore, we asked whether this process might underlie the m1
our results support a model whereby activated RhoA mAChR±mediated suppression of Kv1.2. We found that
translocates to themembrane fraction, where it interacts cells which had been pretreated with C3 exoenzyme
with the amino terminus of Kv1.2. were resistant to m1 mAChR±mediated suppression,
Does the association of RhoA with Kv1.2 have any suggesting that RhoA acts as a necessary component
physiological effect on ionic current generated by Kv1.2 in this receptor-activated signaling pathway (Figures 5B
channels? Both the wild-type and the activated form of and 6). Our data suggest that m1 mAChR signaling
RhoA (RhoA-QL) induced a suppression of ionic current through phospholipase C (Peralta et al., 1988; Carroll et
generated by Kv1.2 channels expressed in Xenopus oo- al., 1995) remained intact in cells that had been treated
cytes. In contrast, a dominant-negative form of RhoA, with C3 exoenzyme, since such cells retained their abil-
N19RhoA, not only failed to suppress Kv1.2 current but ity to generate calcium transients (Figure 5B, inset). Fur-
produced an increase in the basal current. This result is ther, we observed that in the presence of C3 exoenzyme,
m1 receptor activation potentiates Kv1.2 current (Figureconsistent with an inhibition by N19RhoA of endogenous
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Figure 6. m1 mAChR±Mediated Suppression
of Kv1.2 Requires RhoA
Stimulation of the m1 mAChR leads to RhoA
activation (GTP-RhoA) and translocation to
the membrane, where it interacts with the
amino terminus of Kv1.2 inducing current re-
duction. In addition to associating with Kv1.2,
GTP-RhoA may activate tyrosine kinase(s)
(TK) that phosphorylate the amino (Huang et
al., 1993) and carboxy (unpublished observa-
tions) termini of Kv1.2 and suppress potas-
sium current. Treatment with C3 exoenzyme
(C3) may block m1 mAChR±mediated sup-
pression of Kv1.2 or may disrupt the binding
between RhoA and Kv1.2. In this model, we
introduce a new player (RhoA) in the signal
transduction pathway leading to channel
suppression described earlier (Huang et al.,
1993).
Experimental Procedures5B). We believe that this process is most likely the result
of the unmasking, by RhoA inhibition, of a parallel signal
Yeast Two-Hybrid Analysisgenerated by m1 mAChRs. It is possible, for example,
DNA encoding amino acids 1±163 of the Kv1.2 channel (amino termi-
that the calcium transient may activate an adenylate nus) was cloned into the pEG202 ªbaitº vector and cotransformed
cyclase, leading to the activation of protein kinase A and with z500,000 human fetal library cDNA clones contained within
the pJG4-5 ªpreyº vector using yeast strain EGY48 (Gietz et al.,the subsequent potentiation of Kv1.2 current. However,
1992; Gyuris et al., 1993). Plasmid DNA recovered from 37 positiveregardless of the mechanism at play, our data indicate
clones was partially sequenced with the dideoxynucleotide chainthat C3 exoenzyme treatment does not disrupt m1
termination method.mAChR signaling per se but instead ablates the RhoA
component of the signal. The finding that activating m1 Cell Culture and Transfections
mAChR after inhibiting RhoA with C3 exoenzyme inhib- For stable expression, Kv1.2 was inserted into pCMV under a zeocin
ited the receptor-mediated suppression of Kv1.2 sug- selectable marker. This plasmid was cotransfected using calcium
phosphate into human 293 embryonic kidney cells (ATCC no.gests that RhoA is involved in this signaling pathway
CRL1573) as previously described (Peralta et al., 1988). For coex-(Figures 5B and 6).
pression studies, Kv1.2 plasmids were transfected into cells pre-However, it is important to note that in orthovanadate-
viously transfected with a plasmid directing the expression of thetreated 293 cells, m1 receptor activation causes sup-
human m1 mAChR (140,000 receptors per cell [Peralta et al., 1988]).
pression of Kv1.2 currentboth in controlcells and cells in Transfected cells were selected for resistance to 500 mg/ml G418
which RhoA had been inactivated using C3 exoenzyme and 250 mg/ml zeocin, and a single clone was selected for use. 293
cells were grown in Dulbecco's modified Eagle's medium supple-(Figures 5C and 5D). C3 exoenzyme±treated cells under-
mented with 10% fetal bovine serum and 100 U/ml penicillin andwent significantly less receptor-mediated suppression
100 mg/ml streptomycin. NG108-15 cells were grown in Dulbecco'sthan control cells, but the suppression that did occur
modified Eagle's medium supplemented with hypoxanthine-amino-
was significant. Inhibiting tyrosine phosphatase activity pterin-thymidine and 10% fetal bovine serum. For all experiments,
with orthovanadate may allow the cumulative effect of the 293 cells were cultured without serum for 48 hr before using.
a relatively weak, receptor-activated tyrosine kinase to
suppress Kv1.2 current. In cells not pretreated with or- Immunoprecipitation Studies
Immunoblotting was done to detect endogenous Kv1.2 and RhoAthovanadate but pretreated with C3 exoenzyme, phos-
in undifferentiated NG108-15 cells using a polyclonal Kv1.2 antibodyphatase activity may act to reverse the cumulative effect
developed in this laboratory against the carboxy terminus of Kv1.2of weak tyrosine kinase activity. Such weak tyrosine
and a monoclonal RhoA antibody (Santa Cruz). Native NG108-15
kinase activity may arise from a RhoA-independent cells were lysed in RIPA buffer (50 mM Tris-HCl [pH 7.4], 1% NP-
pathway. Alternatively, a small percentage of the total 40, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EDTA and
cellular RhoA may not have been inactivated by C3 exo- protease inhibitors), and insoluble material was pelleted by centrifu-
gation at 16,000 g for 5 min. Supernatants were incubated with 1enzyme and may therefore have been available to evoke
mg of anti-RhoA antibody for 1 hr at 48C. Immunocomplexes weresome tyrosine kinase activity.
bound to protein G±Sepharose beads (Sigma) for 1±2 hr at 48C,Therefore, while it is clear that RhoA has an important
washed three times with 1 ml lysis buffer, analyzed by immunoblot-
role in receptor-mediated suppression of Kv1.2 current, ting with rabbit polyclonal anti-Kv1.2 antisera, and developed using
the mechanism by which that suppression occurs re- enhanced chemiluminescence. For immunoprecipitations in a stable
mains unknown. RhoA may modulate tyrosine phos- transfected 293-Kv1.2 cell line, we prepared membrane fractions
(Huang et al., 1993), which were subsequently immunoprecipitatedphorylation of Kv1.2 by regulating tyrosine kinases, but
following the same protocol as for NG108 cells.it may also bring about current suppression by virtue of
its physical association with the channel or even through
Construction of Mutant Kv1.2 Channelsits modulation of the cytoskeleton. Such mechanisms
A deletion mutant lacking the distal 124 amino acids (termed Kv1.2-
may comprise part of a more complex mechanism for DN125) was created by PCR. The nucleotide sequence of the mutant
tyrosine kinase±dependent suppression of Kv1.2 than Kv1.2-DN125 was confirmed by DNA sequencing. The Kv1.2-Y132F
mutant was described previously (Huang et al., 1993).had originally been envisioned.
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In Vitro Binding Experiments with Fura-2 loaded cells were placed in a glass-bottomed Petri dish
containing external saline. The dish was maintained at 378C for theThe complete Kv1.2 (499 amino acids) cDNA, Kv1.2 amino terminus
(163 aa), or Kv1.2-DN125 (374 aa) were subcloned in pBluescript duration of the experiment. Carbachol (1 mM) was applied after a 10
min incubation period to simulate the electrophysiological recordingSK1. In vitro capped RNA transcripts were synthesized from linear-
ized plasmid template DNA with RNA polymerase using standard conditions. Calibrated calcium values were determined using ra-
tiometric analysis as described (Grynkiewicz et al., 1985).protocols (Melton et al., 1984). In vitro transcripts (2 mg/ml) were
used to perform in vitro translation experiments using the rabbit
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